急性缺血性脑卒中的溶栓治疗

Thrombolytic treatment of acute ischemic stroke

目的: 观察国产尿激酶(天普乐欣)治疗急性缺血性脑卒中的疗效及安全性。方法: 对45 例急性缺血性脑卒中患者进行临床观察。结果: 溶栓治疗后显效者11 例(25% ), 即肌力改善≥2 级, 同时伴肢体活动、言语功能及面瘫、舌瘫改善, 其余(66.6% )都有不同程度改善, 未见严重不良反应。结论: 小剂量短程溶栓疗法是治疗急性缺血性脑卒中确实有效的措施; 溶栓治疗效果与缺血性脑卒中发病时间密切相关, 强调早期诊断,

Objective: To study the curative effect and safety of urokinase (UK) therapy for acute ischemic stroke. Methods: Forty five patients with acute ischemic stroke were collected, the several clinical parameters of thrombolytic therapy group and control group were analyzed. Results: The total clinical effective rate in thrombolytic group was 91%, including improvement of myodynamia, limbs' movement, speaking and so on, severe ill effects in thrombolytic group were not discovered. Conclusion: The data suggest that low dose and short period thrombolytic therapy was one of the effective measures to treat acute ischemic stroke. The thrombolytic curative effect had closely relation to the attacking time of acute ischemic stroke, hence early diagnosis and treatment should be taken in acute ischemic stroke.\;